Singapore Accuron Technologies Tender

PRECISION engineering and technology group Accuron Technologies a wholly owned subsidiary of Temasek Holdings announced on Thursday that it will spin out its medical device business to be directly owned by Temasek.The Accuron MedTech Group Accuron MedTech said to be South-east Asias largest medical device business will be established as a leading vertically integrated urology business.Accuron Technologies said that the move will allow Accuron MedTechs management team to better focus on global medtech growth and investment opportunities. It is anticipated that the process will be completed by March 2019.Philip Yeo chairman of Accuron Technologies Limited said Accuron MedTech has been managed as an independent division of Accuron Technologies for some time now. The spin out will enable Accuron MedTech to be more agile in managing its operations putting it on a stronger platform for sustained growth and technology commercialisation.